Author

Björn Frendéus

Observed names: B Frendeus, B Frendéus, B. Frendeus, B. Frendéus, Bjorn Frendeus, Bjorn Frendéus, Bjorn L Frendeus, Bjorn L. Frendéus, Björn Frendéus, BjÖRn Frendéus, Björn Frendeus, Björn L. Frendéus, Frendeus Bjorn, Frendéus, Bjorn, Frendéus, Björn

Institutions: Southampton General Hospital, BioInvent (Sweden), University of Southampton

Observed institutions: Harvard University, Lund University, Southampton General Hospital, BioInvent (Sweden), University of Southampton, Institut für Laboratoriumsmedizin, Imperial College London

ORCID: 0000-0003-3177-8686

Observed ORCID: 0000-0003-3177-8686

OpenAlex ID: A5013771543

Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies

2018 · Frederick Arce Vargas, Andrew J.S. Furness, et al. · Cancer Cell · 605

Neutrophil Recruitment and Resistance to Urinary Tract Infection

1999 · Masashi Haraoka, Long Hang, et al. · The Journal of Infectious Diseases · 268

Interleukin 8 Receptor Deficiency Confers Susceptibility to Acute Experimental Pyelonephritis and May Have a Human Counterpart

2000 · Björn Frendéus, Gabriela Godaly, et al. · The Journal of Experimental Medicine · 203

Transepithelial Neutrophil Migration Is CXCR1 Dependent In Vitro and Is Defective in IL-8 Receptor Knockout Mice

2000 · Gabriela Godaly, Long Hang, et al. · The Journal of Immunology · 188

Recombinant Antibodies to an Oxidized Low-Density Lipoprotein Epitope Induce Rapid Regression of Atherosclerosis in Apobec-1−/−/Low-Density Lipoprotein Receptor−/−Mice

2007 · Alexandru Schiopu, Björn Frendéus, et al. · Journal of the American College of Cardiology · 178

Escherichia coli P fimbriae utilize the Toll‐like receptor 4 pathway for cell activation

2001 · Björn Frendéus, Caroline Wachtler, et al. · Molecular Microbiology · 175

Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function

2018 · Sarah L. Buchan, Lang Dou, et al. · Immunity · 167

Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection

2001 · G Godaly, G Bergsten, et al. · Journal of Leukocyte Biology · 162

Interleukin‐8 Receptor Knockout Mice Have Subepithelial Neutrophil Entrapment and Renal Scarring following Acute Pyelonephritis

2000 · Long Hang, Björn Frendéus, et al. · The Journal of Infectious Diseases · 136

Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo

2015 · Ali Roghanian, Ingrid Teige, et al. · Cancer Cell · 135

Type 1 fimbriae deliver an LPS‐ and TLR4‐dependent activation signal to CD14‐negative cells

2001 · Maria Hedlund, Björn Frendéus, et al. · Molecular Microbiology · 130

FDG-PET Imaging for Oxidized LDL in Stable Atherosclerotic Disease: A Phase II Study of Safety, Tolerability, and Anti-Inflammatory Activity

2014 · Joshua Lehrer-Graiwer, Parmanand Singh, et al. · JACC. Cardiovascular imaging · 95

Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity

2013 · Andrew T. Vaughan, Chisako Iriyama, et al. · Blood · 76

A Human ICAM-1 Antibody Isolated by a Function-First Approach Has Potent Macrophage-Dependent Antimyeloma Activity In Vivo

2013 · Niina Veitonmäki, Markus Hansson, et al. · Cancer Cell · 73

Interleukin‐8 Receptor Deficiency Confers Susceptibility to Acute Pyelonephritis

2001 · Björn Frendéus, Gabriela Godaly, et al. · The Journal of Infectious Diseases · 72

LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation

2020 · Muchaala Yeboah, Charys Papagregoriou, et al. · JCI Insight · 63

Human leukocyte immunoglobulin-like receptors in health and disease

2023 · Silvia Redondo-García, Christopher Barritt, et al. · Frontiers in Immunology · 56

Role of fimbriae‐mediated adherence for neutrophil migration across Escherichia coli‐infected epithelial cell layers

1998 · G. Godaly, B. Frendéus, et al. · Molecular Microbiology · 56

Targeting the Antibody Checkpoints to Enhance Cancer Immunotherapy–Focus on FcγRIIB

2019 · Ingrid Teige, Linda Mårtensson, et al. · Frontiers in Immunology · 55

Upregulation of FcγRIIb on monocytes is necessary to promote the superagonist activity of TGN1412

2014 · Khiyam Hussain, Chantal E. Hargreaves, et al. · Blood · 55

Toll‐like Receptor Signaling and Chemokine Receptor Expression Influence the Severity of Urinary Tract Infection

2001 · C. Svanborg, B. Frendéus, et al. · The Journal of Infectious Diseases · 54

Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques

2013 · Shijie Li, Paul Kievit, et al. · Molecular Metabolism · 51

A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma

2017 · Stina Wichert, Gunnar Juliusson, et al. · PLoS ONE · 50

A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma

2015 · Markus Hansson, Peter Gimsing, et al. · Clinical Cancer Research · 49

The ‘innate’ host response protects and damages the infected urinary tract

2001 · Catharina Svanborg, GÖRan Bergsten, et al. · Annals of Medicine · 48

Works count: 135

Citation count: 3,753

H-index: 31

I10-index: 42